[PDF] Top 20 Synthetic antibodies targeting HIV-1 infectivity
Has 10000 "Synthetic antibodies targeting HIV-1 infectivity" found on our website. Below are the top 20 most common "Synthetic antibodies targeting HIV-1 infectivity".
Synthetic antibodies targeting HIV-1 infectivity
... eradicate HIV-1 from the body which results in long-term toxicity and inevitably leads to the emergence of resistant strains, as well as being associated with a high level of severe side ...against ... See full document
214
Association of enhanced HIV-1 neutralization by a single Y681H substitution in gp41 with increased gp120-CD4 interaction and macrophage infectivity.
... a HIV-1 clade C Env variant with histidine in place of much conserved tyrosine at position 681 in gp41 MPER from a recently infected HIV-1 positive Indian patient that showed enhanced ... See full document
14
HIV-1 binding and neutralizing antibodies of injecting drug users
... of HIV-1-positive Bra- zilian sera (4) showed an especially frequent reactivity against synthetic viral envelope peptides in IDU plasma compared to plasma from individuals belonging to other ... See full document
8
The identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancement.
... EDTA, 1 m M PMSF, 1 m g/ml aprotinin, 1 m g/ml leupeptin, and 1 m g/ml ...The antibodies used were as follows: anti-Gag (#65-004; BioAcademia, Osaka, Japan), anti-Nef (#2949; NIH AIDS ... See full document
12
Serotyping HIV-1 with V3 peptides: detection of high avidity antibodies presenting clade-specific reactivity
... short synthetic peptides of the V3 region of HIV-1 gp120, which is the main target for neutraliz- ing ...of synthetic peptides of HIV-1 subtypes and using urea washes to detect ... See full document
7
Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.
... of HIV-1 is likely to require a strategy that directs antibody (Ab) responses toward conserved regions of the viral Envelope ...(NAbs) targeting these regions through vaccination has proven to be ... See full document
33
Recombinant intracellular antibodies for molecular gene therapy of HIV-1 infection
... Thus an intrabody can also be reduced in size to a single functional variable domain. For this designed format, a single VH domain, known as an IDab, possesses excellent solubility, stability and expression within ... See full document
252
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
... the infectivity of cell-free virions, we investigated a functional link between Nef and ...alters HIV-1 sensitivity to agents that target distinct features of ...monoclonal antibodies (nAbs) ... See full document
15
Targeting membrane proteins of latently infected CD4+T cells providing a starting point to the eradication of HIV-1
... As we have seen before, antibody diversity in higher organisms is assured by combinatorial recombination of germ‐line antibody genes associated with somatic hypermutation. This means that each individual organism caries ... See full document
76
Development of specific recombinant single-domain antibodies against gp120 HIV-1 glycoprotein and their selection by Phage Display
... class 1 fusion inhibitor and was the first entry inhibitor approved for clinical use (Henrich & Kuritzkes, ...36-amino-acid synthetic peptide, whose sequence corresponds to that of the HR-2 region of ... See full document
96
Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.
... monoclonal antibodies have defined four major targets for broadly neutralizing antibodies on the HIV-1 glycoprotein ...binding antibodies (predominantly at positions N156/N160 and ... See full document
16
Development of synthetic light-chain antibodies as novel and potent HIV fusion inhibitors
... ilarly to rabbit F63 and proved to be more stable than its rabbit homolog because of alanine substitution of unpaired cysteines performed along with F63 humaniza- tion (data not shown). It is conceivable that the rabbit- ... See full document
11
Targeting Heme with Single Domain Antibodies
... a synthetic phage-display single domain antibody (sdAb) (Goncalves, 2008;Santos, 2014) derived from a highly soluble and stable VL scaffold (Goncalves et ...The synthetic VL library repertoire, consisting ... See full document
228
Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity.
... during HIV-1 ...with HIV-1 [28,29], is released by plasmacytoid dendritic cells in an innate antiviral response ...in HIV viremia suggesting that monocyte function was impaired during ... See full document
9
Infeção trans de microglia e astrócitos por estirpes primárias de HIV-1 e HIV-2
... do HIV no SNC. a) A teoria mais apoiada em relação à entrada do HIV no cérebro é a do Cavalo de Tróia (“Trojan Horse”), com a passagem do vírus dentro de a) macrófagos infetados e b) linfócitos T CD4+ ... See full document
49
Targeting tissular immune response improves diagnostic performance of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease.
... various antibodies against microbial epitopes have been studied in CD and UC but many of these studies concluded that these serological markers were of poor diagnostic interest by a great lack of sensitivity for ... See full document
8
Passive Transfer of HIV-1 Antibodies and Drug Resistant Virus during a Health Care Worker Accident: Implications for HCW Post-Exposure Management
... drug-resistant HIV-1 ...(third-generation HIV-1 and 2 EIA) and Western blot (indeterminate classification with gp120 +/- and gp160 1+bands) performed on the blood sample collected from ... See full document
13
Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals.
... inserted HIV genes from MVA-B are somehow involved in inducing lower secretion of cytokines comparing with MVA, perhaps as a result of the higher induction of apoptosis of MVA-B (Figure ... See full document
17
Infectivity and Disease Clinical Outcome
... hydrogen peroxide (30vv) in 0.01 M Phosphate Buffered Saline (PBS; pH 7.2) to block endogenous peroxidase activity, followed by incubation with normal goat serum (1:100 dilution) to block non-specific ... See full document
16
Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag.
... release. HIV-1 uses a PTAP motif as its primary L domain, which interacts with the ESCRT-I component ...although HIV-1 Gag lacks PPxY motifs, the release of HIV-1 L domain ... See full document
13
temas relacionados